Changes in the Serum Levels of Human Chorionic Gonadotropin and the Pulsatility Index of Uterine Arteries during Conservative Management of Retained Adherent Placenta
暂无分享,去创建一个
[1] V. Dadhwal,et al. Medical management of placenta accreta , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[2] C. Hobel,et al. Placenta previa percreta with bladder involvement: new considerations and review of the literature , 1997, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[3] J. Barton,et al. The management of placenta percreta: conservative and operative strategies. , 1996, American journal of obstetrics and gynecology.
[4] John D. Davis,et al. PERSISTENT PLACENTA INCRETA: A COMPLICATION OF CONSERVATIVE MANAGEMENT OF PRESUMED PLACENTA ACCRETA , 1996, Obstetrics and gynecology.
[5] R. Barini,et al. Placenta percreta with silent rupture of the uterus. , 1996, Sao Paulo medical journal = Revista paulista de medicina.
[6] M. Huertas,et al. Sonographic follow‐up of a placenta left in situ after delivery of the fetus in an abdominal pregnancy , 1996, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[7] L. Lee,et al. Successful conservative management of placenta percreta with rectal involvement in a primigravida , 1995, Acta obstetricia et gynecologica Scandinavica.
[8] D. Sherer,et al. Failure of methotrexate treatment for term placenta percreta. , 1994, American journal of obstetrics and gynecology.
[9] S. Caritis,et al. Nonsurgical management of placenta percreta: A case report , 1994, Obstetrics and gynecology.
[10] T. Sundin,et al. Placenta percreta with bladder invasion: report of three cases. , 2008, American journal of perinatology.
[11] J. Legarth,et al. Placenta previa-percreta: magnetic resonance imaging findings and methotrexate therapy after hysterectomy. , 1993, American journal of obstetrics and gynecology.
[12] A. Tekay,et al. A longitudinal Doppler ultrasonographic assessment of the alterations in peripheral vascular resistance of uterine arteries and ultrasonographic findings of the involuting uterus during the puerperium. , 1993, American journal of obstetrics and gynecology.
[13] A. Herman,et al. Repeated ultrasonography and intramuscular methotrexate in the conservative management of residual adherent placenta , 1992, Journal of clinical ultrasound : JCU.
[14] U. Löhrs,et al. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies , 1991, Virchows Archiv. B, Cell pathology including molecular pathology.
[15] P. Meis,et al. The effect of placental location on uterine artery flow velocity waveforms. , 1988, American journal of obstetrics and gynecology.
[16] J. Bulmer,et al. Expression of the proliferation markers Ki67 and transferrin receptor by human trophoblast populations. , 1988, Journal of reproductive immunology.
[17] L. Grunfeld,et al. Development of uterine artery compliance in pregnancy as detected by Doppler ultrasound. , 1986, American journal of obstetrics and gynecology.
[18] I. Ingemarsson,et al. Medical Treatment of Placenta Accreta with Methotrexate , 1986, Acta obstetricia et gynecologica Scandinavica.
[19] J. Winter,et al. Postpartum disappearance of chorionic gonadotropin from the maternal and neonatal circulations. , 1985, American journal of obstetrics and gynecology.
[20] J. Read,et al. Placenta Accreta: Changing Clinical Aspects and Outcome , 1980, Obstetrics and gynecology.
[21] H. Fox. PLACENTA ACCRETA, 1945–1969 , 1972 .